What is exocrine pancreatic cancer?
Exocrine pancreatic cancer is the most common type of pancreatic cancer. About 95 percent of more than 43,000 annual cases of pancreatic cancers begin in glands or ducts of the exocrine pancreas, where digestive juices are produced. Two-thirds of these cancers are found in the head of the pancreas, the remainder in the tail.
Who is most likely to have exocrine pancreatic cancer?
Exocrine Pancreatic Cancer is more common among men and African-Americans. Risk factors include smoking, long-standing diabetes, chronic pancreatitis, and certain hereditary conditions including hereditary pancreatitis, multiple endocrine neoplasia type 1 syndrome, hereditary nonpolyposis colon cancer (HNPCC; Lynch syndrome), von Hippel-Lindau syndrome, ataxia-telangiectasia, and the familial atypical multiple mole melanoma syndrome. Other risk factors include a family history of pancreatic cancer, older age, and obesity. Exposure to certain pesticides, dyes, or chemicals related to gasoline is another risk.
What characterizes exocrine pancreatic cancer?
Exocrine pancreatic cancer is difficult to detect early because its symptoms are similar to other illnesses and because the pancreas is hidden behind other organs. Often, this type of cancer is not detected until it has spread. Symptoms include jaundice, abdominal pain, digestive problems, blood clots or fatty tissue abnormalities, chronic fatigue, fainting, or weight gain without eating too much. These symptoms coupled with the risk factors described earlier warrant a trip to see a doctor as soon as possible.
How does the pathologist diagnose exocrine pancreatic cancer?
Your primary care physician will order blood tests for the pathologist to review. Your medical team also may order imaging tests such as chest x-rays; CT, PET or MRI scans; or endoscopic ultrasound (EUS) to view inside the body.
Laparoscopy allows physicians to view inside the body using a thin, lighted tube inserted through small incisions in the abdominal wall. Endoscopic retrograde cholangiopancreatography (ERCP) examines the bile ducts for narrowing or blockages sometimes associated with pancreatic cancer. Biopsy specimens, or tissue samples, can be gathered during both of these procedures.
What else does the pathologist look for?
The pathologist reviews the biopsy specimens and the results of all tests to make a diagnosis. If cancer is found, the pathologist can determine the stage of the cancer. Stage 1 exocrine pancreatic cancers are small and confined to the pancreas, and stage 4 tumors have spread beyond areas near the pancreas. Stages 2 and 3 describe conditions in between these two extremes. The chance of recovery depends on the type of exocrine pancreatic cancer, how far the cancer has spread, and your overall health.
How do doctors determine what treatment will be necessary?
The pathologist consults with your primary care physician or specialist after reviewing the test results and determining the stage of the cancer. Together, using their combined experience and knowledge, they determine treatment options most appropriate for your condition. It’s important to learn as much as you can about your treatment options and make the decision that’s right for you.
What kinds of treatments are available for exocrine pancreatic cancer?
Exocrine pancreatic cancer can be treated with surgery, chemotherapy, radiation therapy, or a combination of these methods. In addition, patients may have treatment to control pain or ease emotional or practical problems.
The most common treatment, surgery removes the cancerous tumor, part or all of the pancreas, and sometimes other tissues or organs. Options include:
If the cancer has spread and cannot be removed, other surgical procedures may be used to relieve pain and other symptoms.
If the cancer has spread outside the pancreas—or if there is a chance it has—your doctor may recommend chemotherapy. This treatment delivers drugs throughout the body and may slow the cancer’s progression and reduce pain. Systemic chemotherapy delivers drugs throughout the body while regional chemotherapy directs the drugs into a particular organ or area of the body, such as the pancreas or abdomen.
The most commonly used chemotherapy drug is 5-fluorouracil (5-FU). Recent studies, however, show gemcitabine to be more effective. Further studies comparing the effectiveness of these two drugs in treating various types of cancers are in progress, as well as other studies combining these two drugs with each other or other chemotherapy drugs.
Radiation therapy—pinpointed high-energy beams—can be used to shrink tumors or destroy cancer cells remaining after surgery. It can be used alone or with surgery or chemotherapy. Two types of radiation therapy can be used—external radiation, during which radiation comes from a large machine, or internal radiation, during which radiation is received through thin tubes (also called implants) inserted in or near the cancerous cells.
Clinical trials of new treatments for exocrine pancreatic cancer may be found at www.cancer.gov/clinicaltrials. These treatments are highly experimental in nature but may be a potential option for advanced cancers. Some trials may involve biologic therapy, which uses the natural defenses of the immune system to fight cancer.
For more information, go to www.cancer.gov (National Cancer Institute) or www.cancer.org (American Cancer Society). Type the keywords: pancreatic cancer or exocrine pancreatic cancer or into the search box.
What kinds of questions should I ask my doctors?
Ask any question you want. There are no questions you should be reluctant to ask. Here are a few to consider:
DEFINITION OF TERMS
Exocrine cells: Cells in the pancreas that produces enzyme juices that help digest food.
Malignant: Cancerous and capable of spreading.
Pathologist: A physician who examines tissues and fluids to diagnose disease to assist in making treatment decisions.
This information was developed by the College of American Pathologists’ Public Affairs Committee in conjunction with the College’s Cancer Committee and Council on Scientific Affairs. The College is providing this information to help you better understand your health. Ultimately any decisions you make about your health, however, should be between you and your doctor.